Global Viable Tumor Samples Supply, Demand and Key Producers, 2023-2029
The global Viable Tumor Samples market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Viable Tumor Samples production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viable Tumor Samples, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viable Tumor Samples that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viable Tumor Samples total production and demand, 2018-2029, (K Units)
Global Viable Tumor Samples total production value, 2018-2029, (USD Million)
Global Viable Tumor Samples production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viable Tumor Samples consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Viable Tumor Samples domestic production, consumption, key domestic manufacturers and share
Global Viable Tumor Samples production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Viable Tumor Samples production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viable Tumor Samples production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Viable Tumor Samples market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include StoreMyTumor, Cureline, Inc., Conversant Bio, Fluxion Biosciences, Miltenyi Biotech, Crown Bioscience, Inc., Indivumed GmbH, Illumina, Inc. and QIAGEN NV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viable Tumor Samples market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Viable Tumor Samples Market, By Region:
1. How big is the global Viable Tumor Samples market?
2. What is the demand of the global Viable Tumor Samples market?
3. What is the year over year growth of the global Viable Tumor Samples market?
4. What is the production and production value of the global Viable Tumor Samples market?
5. Who are the key producers in the global Viable Tumor Samples market?
6. What are the growth factors driving the market demand?
This report studies the global Viable Tumor Samples production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viable Tumor Samples, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viable Tumor Samples that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viable Tumor Samples total production and demand, 2018-2029, (K Units)
Global Viable Tumor Samples total production value, 2018-2029, (USD Million)
Global Viable Tumor Samples production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viable Tumor Samples consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Viable Tumor Samples domestic production, consumption, key domestic manufacturers and share
Global Viable Tumor Samples production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Viable Tumor Samples production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Viable Tumor Samples production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Viable Tumor Samples market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include StoreMyTumor, Cureline, Inc., Conversant Bio, Fluxion Biosciences, Miltenyi Biotech, Crown Bioscience, Inc., Indivumed GmbH, Illumina, Inc. and QIAGEN NV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viable Tumor Samples market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Viable Tumor Samples Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Flash Frozen Tumor Samples
- Fresh Tumor Samples
- Lung Cancer
- Prostate Cancer
- Breast Cancer
- Lymphoma
- Leukemia
- Others
- StoreMyTumor
- Cureline, Inc.
- Conversant Bio
- Fluxion Biosciences
- Miltenyi Biotech
- Crown Bioscience, Inc.
- Indivumed GmbH
- Illumina, Inc.
- QIAGEN NV
- Neogenomics Laboratories, Inc.
- HTG Molecular Diagnostics
- Genomic Health, Inc.
- Thermo Fischer
- BGI Genomics Co., Ltd.
- Bruker Biosciences Corp.
- Cepheid, Inc.
- Promega Corporation
- Applied Biosystems, Inc.
- Natera
- Agilent
1. How big is the global Viable Tumor Samples market?
2. What is the demand of the global Viable Tumor Samples market?
3. What is the year over year growth of the global Viable Tumor Samples market?
4. What is the production and production value of the global Viable Tumor Samples market?
5. Who are the key producers in the global Viable Tumor Samples market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Viable Tumor Samples Introduction
1.2 World Viable Tumor Samples Supply & Forecast
1.2.1 World Viable Tumor Samples Production Value (2018 & 2022 & 2029)
1.2.2 World Viable Tumor Samples Production (2018-2029)
1.2.3 World Viable Tumor Samples Pricing Trends (2018-2029)
1.3 World Viable Tumor Samples Production by Region (Based on Production Site)
1.3.1 World Viable Tumor Samples Production Value by Region (2018-2029)
1.3.2 World Viable Tumor Samples Production by Region (2018-2029)
1.3.3 World Viable Tumor Samples Average Price by Region (2018-2029)
1.3.4 North America Viable Tumor Samples Production (2018-2029)
1.3.5 Europe Viable Tumor Samples Production (2018-2029)
1.3.6 China Viable Tumor Samples Production (2018-2029)
1.3.7 Japan Viable Tumor Samples Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viable Tumor Samples Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Viable Tumor Samples Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Viable Tumor Samples Demand (2018-2029)
2.2 World Viable Tumor Samples Consumption by Region
2.2.1 World Viable Tumor Samples Consumption by Region (2018-2023)
2.2.2 World Viable Tumor Samples Consumption Forecast by Region (2024-2029)
2.3 United States Viable Tumor Samples Consumption (2018-2029)
2.4 China Viable Tumor Samples Consumption (2018-2029)
2.5 Europe Viable Tumor Samples Consumption (2018-2029)
2.6 Japan Viable Tumor Samples Consumption (2018-2029)
2.7 South Korea Viable Tumor Samples Consumption (2018-2029)
2.8 ASEAN Viable Tumor Samples Consumption (2018-2029)
2.9 India Viable Tumor Samples Consumption (2018-2029)
3 WORLD VIABLE TUMOR SAMPLES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Viable Tumor Samples Production Value by Manufacturer (2018-2023)
3.2 World Viable Tumor Samples Production by Manufacturer (2018-2023)
3.3 World Viable Tumor Samples Average Price by Manufacturer (2018-2023)
3.4 Viable Tumor Samples Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Viable Tumor Samples Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Viable Tumor Samples in 2022
3.5.3 Global Concentration Ratios (CR8) for Viable Tumor Samples in 2022
3.6 Viable Tumor Samples Market: Overall Company Footprint Analysis
3.6.1 Viable Tumor Samples Market: Region Footprint
3.6.2 Viable Tumor Samples Market: Company Product Type Footprint
3.6.3 Viable Tumor Samples Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Viable Tumor Samples Production Value Comparison
4.1.1 United States VS China: Viable Tumor Samples Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Viable Tumor Samples Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Viable Tumor Samples Production Comparison
4.2.1 United States VS China: Viable Tumor Samples Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Viable Tumor Samples Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Viable Tumor Samples Consumption Comparison
4.3.1 United States VS China: Viable Tumor Samples Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Viable Tumor Samples Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Viable Tumor Samples Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Viable Tumor Samples Production Value (2018-2023)
4.4.3 United States Based Manufacturers Viable Tumor Samples Production (2018-2023)
4.5 China Based Viable Tumor Samples Manufacturers and Market Share
4.5.1 China Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Viable Tumor Samples Production Value (2018-2023)
4.5.3 China Based Manufacturers Viable Tumor Samples Production (2018-2023)
4.6 Rest of World Based Viable Tumor Samples Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Viable Tumor Samples Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Viable Tumor Samples Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Viable Tumor Samples Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Flash Frozen Tumor Samples
5.2.2 Fresh Tumor Samples
5.3 Market Segment by Type
5.3.1 World Viable Tumor Samples Production by Type (2018-2029)
5.3.2 World Viable Tumor Samples Production Value by Type (2018-2029)
5.3.3 World Viable Tumor Samples Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Viable Tumor Samples Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Lung Cancer
6.2.2 Prostate Cancer
6.2.3 Breast Cancer
6.2.4 Lymphoma
6.2.5 Leukemia
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World Viable Tumor Samples Production by Application (2018-2029)
6.3.2 World Viable Tumor Samples Production Value by Application (2018-2029)
6.3.3 World Viable Tumor Samples Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 StoreMyTumor
7.1.1 StoreMyTumor Details
7.1.2 StoreMyTumor Major Business
7.1.3 StoreMyTumor Viable Tumor Samples Product and Services
7.1.4 StoreMyTumor Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 StoreMyTumor Recent Developments/Updates
7.1.6 StoreMyTumor Competitive Strengths & Weaknesses
7.2 Cureline, Inc.
7.2.1 Cureline, Inc. Details
7.2.2 Cureline, Inc. Major Business
7.2.3 Cureline, Inc. Viable Tumor Samples Product and Services
7.2.4 Cureline, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Cureline, Inc. Recent Developments/Updates
7.2.6 Cureline, Inc. Competitive Strengths & Weaknesses
7.3 Conversant Bio
7.3.1 Conversant Bio Details
7.3.2 Conversant Bio Major Business
7.3.3 Conversant Bio Viable Tumor Samples Product and Services
7.3.4 Conversant Bio Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Conversant Bio Recent Developments/Updates
7.3.6 Conversant Bio Competitive Strengths & Weaknesses
7.4 Fluxion Biosciences
7.4.1 Fluxion Biosciences Details
7.4.2 Fluxion Biosciences Major Business
7.4.3 Fluxion Biosciences Viable Tumor Samples Product and Services
7.4.4 Fluxion Biosciences Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Fluxion Biosciences Recent Developments/Updates
7.4.6 Fluxion Biosciences Competitive Strengths & Weaknesses
7.5 Miltenyi Biotech
7.5.1 Miltenyi Biotech Details
7.5.2 Miltenyi Biotech Major Business
7.5.3 Miltenyi Biotech Viable Tumor Samples Product and Services
7.5.4 Miltenyi Biotech Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Miltenyi Biotech Recent Developments/Updates
7.5.6 Miltenyi Biotech Competitive Strengths & Weaknesses
7.6 Crown Bioscience, Inc.
7.6.1 Crown Bioscience, Inc. Details
7.6.2 Crown Bioscience, Inc. Major Business
7.6.3 Crown Bioscience, Inc. Viable Tumor Samples Product and Services
7.6.4 Crown Bioscience, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Crown Bioscience, Inc. Recent Developments/Updates
7.6.6 Crown Bioscience, Inc. Competitive Strengths & Weaknesses
7.7 Indivumed GmbH
7.7.1 Indivumed GmbH Details
7.7.2 Indivumed GmbH Major Business
7.7.3 Indivumed GmbH Viable Tumor Samples Product and Services
7.7.4 Indivumed GmbH Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Indivumed GmbH Recent Developments/Updates
7.7.6 Indivumed GmbH Competitive Strengths & Weaknesses
7.8 Illumina, Inc.
7.8.1 Illumina, Inc. Details
7.8.2 Illumina, Inc. Major Business
7.8.3 Illumina, Inc. Viable Tumor Samples Product and Services
7.8.4 Illumina, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Illumina, Inc. Recent Developments/Updates
7.8.6 Illumina, Inc. Competitive Strengths & Weaknesses
7.9 QIAGEN NV
7.9.1 QIAGEN NV Details
7.9.2 QIAGEN NV Major Business
7.9.3 QIAGEN NV Viable Tumor Samples Product and Services
7.9.4 QIAGEN NV Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 QIAGEN NV Recent Developments/Updates
7.9.6 QIAGEN NV Competitive Strengths & Weaknesses
7.10 Neogenomics Laboratories, Inc.
7.10.1 Neogenomics Laboratories, Inc. Details
7.10.2 Neogenomics Laboratories, Inc. Major Business
7.10.3 Neogenomics Laboratories, Inc. Viable Tumor Samples Product and Services
7.10.4 Neogenomics Laboratories, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Neogenomics Laboratories, Inc. Recent Developments/Updates
7.10.6 Neogenomics Laboratories, Inc. Competitive Strengths & Weaknesses
7.11 HTG Molecular Diagnostics
7.11.1 HTG Molecular Diagnostics Details
7.11.2 HTG Molecular Diagnostics Major Business
7.11.3 HTG Molecular Diagnostics Viable Tumor Samples Product and Services
7.11.4 HTG Molecular Diagnostics Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 HTG Molecular Diagnostics Recent Developments/Updates
7.11.6 HTG Molecular Diagnostics Competitive Strengths & Weaknesses
7.12 Genomic Health, Inc.
7.12.1 Genomic Health, Inc. Details
7.12.2 Genomic Health, Inc. Major Business
7.12.3 Genomic Health, Inc. Viable Tumor Samples Product and Services
7.12.4 Genomic Health, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Genomic Health, Inc. Recent Developments/Updates
7.12.6 Genomic Health, Inc. Competitive Strengths & Weaknesses
7.13 Thermo Fischer
7.13.1 Thermo Fischer Details
7.13.2 Thermo Fischer Major Business
7.13.3 Thermo Fischer Viable Tumor Samples Product and Services
7.13.4 Thermo Fischer Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Thermo Fischer Recent Developments/Updates
7.13.6 Thermo Fischer Competitive Strengths & Weaknesses
7.14 BGI Genomics Co., Ltd.
7.14.1 BGI Genomics Co., Ltd. Details
7.14.2 BGI Genomics Co., Ltd. Major Business
7.14.3 BGI Genomics Co., Ltd. Viable Tumor Samples Product and Services
7.14.4 BGI Genomics Co., Ltd. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 BGI Genomics Co., Ltd. Recent Developments/Updates
7.14.6 BGI Genomics Co., Ltd. Competitive Strengths & Weaknesses
7.15 Bruker Biosciences Corp.
7.15.1 Bruker Biosciences Corp. Details
7.15.2 Bruker Biosciences Corp. Major Business
7.15.3 Bruker Biosciences Corp. Viable Tumor Samples Product and Services
7.15.4 Bruker Biosciences Corp. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Bruker Biosciences Corp. Recent Developments/Updates
7.15.6 Bruker Biosciences Corp. Competitive Strengths & Weaknesses
7.16 Cepheid, Inc.
7.16.1 Cepheid, Inc. Details
7.16.2 Cepheid, Inc. Major Business
7.16.3 Cepheid, Inc. Viable Tumor Samples Product and Services
7.16.4 Cepheid, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Cepheid, Inc. Recent Developments/Updates
7.16.6 Cepheid, Inc. Competitive Strengths & Weaknesses
7.17 Promega Corporation
7.17.1 Promega Corporation Details
7.17.2 Promega Corporation Major Business
7.17.3 Promega Corporation Viable Tumor Samples Product and Services
7.17.4 Promega Corporation Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Promega Corporation Recent Developments/Updates
7.17.6 Promega Corporation Competitive Strengths & Weaknesses
7.18 Applied Biosystems, Inc.
7.18.1 Applied Biosystems, Inc. Details
7.18.2 Applied Biosystems, Inc. Major Business
7.18.3 Applied Biosystems, Inc. Viable Tumor Samples Product and Services
7.18.4 Applied Biosystems, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Applied Biosystems, Inc. Recent Developments/Updates
7.18.6 Applied Biosystems, Inc. Competitive Strengths & Weaknesses
7.19 Natera
7.19.1 Natera Details
7.19.2 Natera Major Business
7.19.3 Natera Viable Tumor Samples Product and Services
7.19.4 Natera Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Natera Recent Developments/Updates
7.19.6 Natera Competitive Strengths & Weaknesses
7.20 Agilent
7.20.1 Agilent Details
7.20.2 Agilent Major Business
7.20.3 Agilent Viable Tumor Samples Product and Services
7.20.4 Agilent Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Agilent Recent Developments/Updates
7.20.6 Agilent Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Viable Tumor Samples Industry Chain
8.2 Viable Tumor Samples Upstream Analysis
8.2.1 Viable Tumor Samples Core Raw Materials
8.2.2 Main Manufacturers of Viable Tumor Samples Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Viable Tumor Samples Production Mode
8.6 Viable Tumor Samples Procurement Model
8.7 Viable Tumor Samples Industry Sales Model and Sales Channels
8.7.1 Viable Tumor Samples Sales Model
8.7.2 Viable Tumor Samples Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Viable Tumor Samples Introduction
1.2 World Viable Tumor Samples Supply & Forecast
1.2.1 World Viable Tumor Samples Production Value (2018 & 2022 & 2029)
1.2.2 World Viable Tumor Samples Production (2018-2029)
1.2.3 World Viable Tumor Samples Pricing Trends (2018-2029)
1.3 World Viable Tumor Samples Production by Region (Based on Production Site)
1.3.1 World Viable Tumor Samples Production Value by Region (2018-2029)
1.3.2 World Viable Tumor Samples Production by Region (2018-2029)
1.3.3 World Viable Tumor Samples Average Price by Region (2018-2029)
1.3.4 North America Viable Tumor Samples Production (2018-2029)
1.3.5 Europe Viable Tumor Samples Production (2018-2029)
1.3.6 China Viable Tumor Samples Production (2018-2029)
1.3.7 Japan Viable Tumor Samples Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viable Tumor Samples Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Viable Tumor Samples Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Viable Tumor Samples Demand (2018-2029)
2.2 World Viable Tumor Samples Consumption by Region
2.2.1 World Viable Tumor Samples Consumption by Region (2018-2023)
2.2.2 World Viable Tumor Samples Consumption Forecast by Region (2024-2029)
2.3 United States Viable Tumor Samples Consumption (2018-2029)
2.4 China Viable Tumor Samples Consumption (2018-2029)
2.5 Europe Viable Tumor Samples Consumption (2018-2029)
2.6 Japan Viable Tumor Samples Consumption (2018-2029)
2.7 South Korea Viable Tumor Samples Consumption (2018-2029)
2.8 ASEAN Viable Tumor Samples Consumption (2018-2029)
2.9 India Viable Tumor Samples Consumption (2018-2029)
3 WORLD VIABLE TUMOR SAMPLES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Viable Tumor Samples Production Value by Manufacturer (2018-2023)
3.2 World Viable Tumor Samples Production by Manufacturer (2018-2023)
3.3 World Viable Tumor Samples Average Price by Manufacturer (2018-2023)
3.4 Viable Tumor Samples Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Viable Tumor Samples Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Viable Tumor Samples in 2022
3.5.3 Global Concentration Ratios (CR8) for Viable Tumor Samples in 2022
3.6 Viable Tumor Samples Market: Overall Company Footprint Analysis
3.6.1 Viable Tumor Samples Market: Region Footprint
3.6.2 Viable Tumor Samples Market: Company Product Type Footprint
3.6.3 Viable Tumor Samples Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Viable Tumor Samples Production Value Comparison
4.1.1 United States VS China: Viable Tumor Samples Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Viable Tumor Samples Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Viable Tumor Samples Production Comparison
4.2.1 United States VS China: Viable Tumor Samples Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Viable Tumor Samples Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Viable Tumor Samples Consumption Comparison
4.3.1 United States VS China: Viable Tumor Samples Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Viable Tumor Samples Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Viable Tumor Samples Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Viable Tumor Samples Production Value (2018-2023)
4.4.3 United States Based Manufacturers Viable Tumor Samples Production (2018-2023)
4.5 China Based Viable Tumor Samples Manufacturers and Market Share
4.5.1 China Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Viable Tumor Samples Production Value (2018-2023)
4.5.3 China Based Manufacturers Viable Tumor Samples Production (2018-2023)
4.6 Rest of World Based Viable Tumor Samples Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Viable Tumor Samples Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Viable Tumor Samples Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Viable Tumor Samples Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Flash Frozen Tumor Samples
5.2.2 Fresh Tumor Samples
5.3 Market Segment by Type
5.3.1 World Viable Tumor Samples Production by Type (2018-2029)
5.3.2 World Viable Tumor Samples Production Value by Type (2018-2029)
5.3.3 World Viable Tumor Samples Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Viable Tumor Samples Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Lung Cancer
6.2.2 Prostate Cancer
6.2.3 Breast Cancer
6.2.4 Lymphoma
6.2.5 Leukemia
6.2.6 Others
6.3 Market Segment by Application
6.3.1 World Viable Tumor Samples Production by Application (2018-2029)
6.3.2 World Viable Tumor Samples Production Value by Application (2018-2029)
6.3.3 World Viable Tumor Samples Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 StoreMyTumor
7.1.1 StoreMyTumor Details
7.1.2 StoreMyTumor Major Business
7.1.3 StoreMyTumor Viable Tumor Samples Product and Services
7.1.4 StoreMyTumor Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 StoreMyTumor Recent Developments/Updates
7.1.6 StoreMyTumor Competitive Strengths & Weaknesses
7.2 Cureline, Inc.
7.2.1 Cureline, Inc. Details
7.2.2 Cureline, Inc. Major Business
7.2.3 Cureline, Inc. Viable Tumor Samples Product and Services
7.2.4 Cureline, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Cureline, Inc. Recent Developments/Updates
7.2.6 Cureline, Inc. Competitive Strengths & Weaknesses
7.3 Conversant Bio
7.3.1 Conversant Bio Details
7.3.2 Conversant Bio Major Business
7.3.3 Conversant Bio Viable Tumor Samples Product and Services
7.3.4 Conversant Bio Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Conversant Bio Recent Developments/Updates
7.3.6 Conversant Bio Competitive Strengths & Weaknesses
7.4 Fluxion Biosciences
7.4.1 Fluxion Biosciences Details
7.4.2 Fluxion Biosciences Major Business
7.4.3 Fluxion Biosciences Viable Tumor Samples Product and Services
7.4.4 Fluxion Biosciences Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Fluxion Biosciences Recent Developments/Updates
7.4.6 Fluxion Biosciences Competitive Strengths & Weaknesses
7.5 Miltenyi Biotech
7.5.1 Miltenyi Biotech Details
7.5.2 Miltenyi Biotech Major Business
7.5.3 Miltenyi Biotech Viable Tumor Samples Product and Services
7.5.4 Miltenyi Biotech Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Miltenyi Biotech Recent Developments/Updates
7.5.6 Miltenyi Biotech Competitive Strengths & Weaknesses
7.6 Crown Bioscience, Inc.
7.6.1 Crown Bioscience, Inc. Details
7.6.2 Crown Bioscience, Inc. Major Business
7.6.3 Crown Bioscience, Inc. Viable Tumor Samples Product and Services
7.6.4 Crown Bioscience, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Crown Bioscience, Inc. Recent Developments/Updates
7.6.6 Crown Bioscience, Inc. Competitive Strengths & Weaknesses
7.7 Indivumed GmbH
7.7.1 Indivumed GmbH Details
7.7.2 Indivumed GmbH Major Business
7.7.3 Indivumed GmbH Viable Tumor Samples Product and Services
7.7.4 Indivumed GmbH Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Indivumed GmbH Recent Developments/Updates
7.7.6 Indivumed GmbH Competitive Strengths & Weaknesses
7.8 Illumina, Inc.
7.8.1 Illumina, Inc. Details
7.8.2 Illumina, Inc. Major Business
7.8.3 Illumina, Inc. Viable Tumor Samples Product and Services
7.8.4 Illumina, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Illumina, Inc. Recent Developments/Updates
7.8.6 Illumina, Inc. Competitive Strengths & Weaknesses
7.9 QIAGEN NV
7.9.1 QIAGEN NV Details
7.9.2 QIAGEN NV Major Business
7.9.3 QIAGEN NV Viable Tumor Samples Product and Services
7.9.4 QIAGEN NV Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 QIAGEN NV Recent Developments/Updates
7.9.6 QIAGEN NV Competitive Strengths & Weaknesses
7.10 Neogenomics Laboratories, Inc.
7.10.1 Neogenomics Laboratories, Inc. Details
7.10.2 Neogenomics Laboratories, Inc. Major Business
7.10.3 Neogenomics Laboratories, Inc. Viable Tumor Samples Product and Services
7.10.4 Neogenomics Laboratories, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Neogenomics Laboratories, Inc. Recent Developments/Updates
7.10.6 Neogenomics Laboratories, Inc. Competitive Strengths & Weaknesses
7.11 HTG Molecular Diagnostics
7.11.1 HTG Molecular Diagnostics Details
7.11.2 HTG Molecular Diagnostics Major Business
7.11.3 HTG Molecular Diagnostics Viable Tumor Samples Product and Services
7.11.4 HTG Molecular Diagnostics Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 HTG Molecular Diagnostics Recent Developments/Updates
7.11.6 HTG Molecular Diagnostics Competitive Strengths & Weaknesses
7.12 Genomic Health, Inc.
7.12.1 Genomic Health, Inc. Details
7.12.2 Genomic Health, Inc. Major Business
7.12.3 Genomic Health, Inc. Viable Tumor Samples Product and Services
7.12.4 Genomic Health, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Genomic Health, Inc. Recent Developments/Updates
7.12.6 Genomic Health, Inc. Competitive Strengths & Weaknesses
7.13 Thermo Fischer
7.13.1 Thermo Fischer Details
7.13.2 Thermo Fischer Major Business
7.13.3 Thermo Fischer Viable Tumor Samples Product and Services
7.13.4 Thermo Fischer Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Thermo Fischer Recent Developments/Updates
7.13.6 Thermo Fischer Competitive Strengths & Weaknesses
7.14 BGI Genomics Co., Ltd.
7.14.1 BGI Genomics Co., Ltd. Details
7.14.2 BGI Genomics Co., Ltd. Major Business
7.14.3 BGI Genomics Co., Ltd. Viable Tumor Samples Product and Services
7.14.4 BGI Genomics Co., Ltd. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 BGI Genomics Co., Ltd. Recent Developments/Updates
7.14.6 BGI Genomics Co., Ltd. Competitive Strengths & Weaknesses
7.15 Bruker Biosciences Corp.
7.15.1 Bruker Biosciences Corp. Details
7.15.2 Bruker Biosciences Corp. Major Business
7.15.3 Bruker Biosciences Corp. Viable Tumor Samples Product and Services
7.15.4 Bruker Biosciences Corp. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Bruker Biosciences Corp. Recent Developments/Updates
7.15.6 Bruker Biosciences Corp. Competitive Strengths & Weaknesses
7.16 Cepheid, Inc.
7.16.1 Cepheid, Inc. Details
7.16.2 Cepheid, Inc. Major Business
7.16.3 Cepheid, Inc. Viable Tumor Samples Product and Services
7.16.4 Cepheid, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Cepheid, Inc. Recent Developments/Updates
7.16.6 Cepheid, Inc. Competitive Strengths & Weaknesses
7.17 Promega Corporation
7.17.1 Promega Corporation Details
7.17.2 Promega Corporation Major Business
7.17.3 Promega Corporation Viable Tumor Samples Product and Services
7.17.4 Promega Corporation Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Promega Corporation Recent Developments/Updates
7.17.6 Promega Corporation Competitive Strengths & Weaknesses
7.18 Applied Biosystems, Inc.
7.18.1 Applied Biosystems, Inc. Details
7.18.2 Applied Biosystems, Inc. Major Business
7.18.3 Applied Biosystems, Inc. Viable Tumor Samples Product and Services
7.18.4 Applied Biosystems, Inc. Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Applied Biosystems, Inc. Recent Developments/Updates
7.18.6 Applied Biosystems, Inc. Competitive Strengths & Weaknesses
7.19 Natera
7.19.1 Natera Details
7.19.2 Natera Major Business
7.19.3 Natera Viable Tumor Samples Product and Services
7.19.4 Natera Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Natera Recent Developments/Updates
7.19.6 Natera Competitive Strengths & Weaknesses
7.20 Agilent
7.20.1 Agilent Details
7.20.2 Agilent Major Business
7.20.3 Agilent Viable Tumor Samples Product and Services
7.20.4 Agilent Viable Tumor Samples Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Agilent Recent Developments/Updates
7.20.6 Agilent Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Viable Tumor Samples Industry Chain
8.2 Viable Tumor Samples Upstream Analysis
8.2.1 Viable Tumor Samples Core Raw Materials
8.2.2 Main Manufacturers of Viable Tumor Samples Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Viable Tumor Samples Production Mode
8.6 Viable Tumor Samples Procurement Model
8.7 Viable Tumor Samples Industry Sales Model and Sales Channels
8.7.1 Viable Tumor Samples Sales Model
8.7.2 Viable Tumor Samples Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Viable Tumor Samples Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Viable Tumor Samples Production Value by Region (2018-2023) & (USD Million)
Table 3. World Viable Tumor Samples Production Value by Region (2024-2029) & (USD Million)
Table 4. World Viable Tumor Samples Production Value Market Share by Region (2018-2023)
Table 5. World Viable Tumor Samples Production Value Market Share by Region (2024-2029)
Table 6. World Viable Tumor Samples Production by Region (2018-2023) & (K Units)
Table 7. World Viable Tumor Samples Production by Region (2024-2029) & (K Units)
Table 8. World Viable Tumor Samples Production Market Share by Region (2018-2023)
Table 9. World Viable Tumor Samples Production Market Share by Region (2024-2029)
Table 10. World Viable Tumor Samples Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Viable Tumor Samples Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Viable Tumor Samples Major Market Trends
Table 13. World Viable Tumor Samples Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Viable Tumor Samples Consumption by Region (2018-2023) & (K Units)
Table 15. World Viable Tumor Samples Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Viable Tumor Samples Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Viable Tumor Samples Producers in 2022
Table 18. World Viable Tumor Samples Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Viable Tumor Samples Producers in 2022
Table 20. World Viable Tumor Samples Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Viable Tumor Samples Company Evaluation Quadrant
Table 22. World Viable Tumor Samples Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Viable Tumor Samples Production Site of Key Manufacturer
Table 24. Viable Tumor Samples Market: Company Product Type Footprint
Table 25. Viable Tumor Samples Market: Company Product Application Footprint
Table 26. Viable Tumor Samples Competitive Factors
Table 27. Viable Tumor Samples New Entrant and Capacity Expansion Plans
Table 28. Viable Tumor Samples Mergers & Acquisitions Activity
Table 29. United States VS China Viable Tumor Samples Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Viable Tumor Samples Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Viable Tumor Samples Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Viable Tumor Samples Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Viable Tumor Samples Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Viable Tumor Samples Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Viable Tumor Samples Production Market Share (2018-2023)
Table 37. China Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Viable Tumor Samples Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Viable Tumor Samples Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Viable Tumor Samples Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Viable Tumor Samples Production Market Share (2018-2023)
Table 42. Rest of World Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Viable Tumor Samples Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Viable Tumor Samples Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Viable Tumor Samples Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Viable Tumor Samples Production Market Share (2018-2023)
Table 47. World Viable Tumor Samples Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Viable Tumor Samples Production by Type (2018-2023) & (K Units)
Table 49. World Viable Tumor Samples Production by Type (2024-2029) & (K Units)
Table 50. World Viable Tumor Samples Production Value by Type (2018-2023) & (USD Million)
Table 51. World Viable Tumor Samples Production Value by Type (2024-2029) & (USD Million)
Table 52. World Viable Tumor Samples Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Viable Tumor Samples Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Viable Tumor Samples Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Viable Tumor Samples Production by Application (2018-2023) & (K Units)
Table 56. World Viable Tumor Samples Production by Application (2024-2029) & (K Units)
Table 57. World Viable Tumor Samples Production Value by Application (2018-2023) & (USD Million)
Table 58. World Viable Tumor Samples Production Value by Application (2024-2029) & (USD Million)
Table 59. World Viable Tumor Samples Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Viable Tumor Samples Average Price by Application (2024-2029) & (US$/Unit)
Table 61. StoreMyTumor Basic Information, Manufacturing Base and Competitors
Table 62. StoreMyTumor Major Business
Table 63. StoreMyTumor Viable Tumor Samples Product and Services
Table 64. StoreMyTumor Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. StoreMyTumor Recent Developments/Updates
Table 66. StoreMyTumor Competitive Strengths & Weaknesses
Table 67. Cureline, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Cureline, Inc. Major Business
Table 69. Cureline, Inc. Viable Tumor Samples Product and Services
Table 70. Cureline, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Cureline, Inc. Recent Developments/Updates
Table 72. Cureline, Inc. Competitive Strengths & Weaknesses
Table 73. Conversant Bio Basic Information, Manufacturing Base and Competitors
Table 74. Conversant Bio Major Business
Table 75. Conversant Bio Viable Tumor Samples Product and Services
Table 76. Conversant Bio Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Conversant Bio Recent Developments/Updates
Table 78. Conversant Bio Competitive Strengths & Weaknesses
Table 79. Fluxion Biosciences Basic Information, Manufacturing Base and Competitors
Table 80. Fluxion Biosciences Major Business
Table 81. Fluxion Biosciences Viable Tumor Samples Product and Services
Table 82. Fluxion Biosciences Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Fluxion Biosciences Recent Developments/Updates
Table 84. Fluxion Biosciences Competitive Strengths & Weaknesses
Table 85. Miltenyi Biotech Basic Information, Manufacturing Base and Competitors
Table 86. Miltenyi Biotech Major Business
Table 87. Miltenyi Biotech Viable Tumor Samples Product and Services
Table 88. Miltenyi Biotech Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Miltenyi Biotech Recent Developments/Updates
Table 90. Miltenyi Biotech Competitive Strengths & Weaknesses
Table 91. Crown Bioscience, Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Crown Bioscience, Inc. Major Business
Table 93. Crown Bioscience, Inc. Viable Tumor Samples Product and Services
Table 94. Crown Bioscience, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Crown Bioscience, Inc. Recent Developments/Updates
Table 96. Crown Bioscience, Inc. Competitive Strengths & Weaknesses
Table 97. Indivumed GmbH Basic Information, Manufacturing Base and Competitors
Table 98. Indivumed GmbH Major Business
Table 99. Indivumed GmbH Viable Tumor Samples Product and Services
Table 100. Indivumed GmbH Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Indivumed GmbH Recent Developments/Updates
Table 102. Indivumed GmbH Competitive Strengths & Weaknesses
Table 103. Illumina, Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Illumina, Inc. Major Business
Table 105. Illumina, Inc. Viable Tumor Samples Product and Services
Table 106. Illumina, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Illumina, Inc. Recent Developments/Updates
Table 108. Illumina, Inc. Competitive Strengths & Weaknesses
Table 109. QIAGEN NV Basic Information, Manufacturing Base and Competitors
Table 110. QIAGEN NV Major Business
Table 111. QIAGEN NV Viable Tumor Samples Product and Services
Table 112. QIAGEN NV Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. QIAGEN NV Recent Developments/Updates
Table 114. QIAGEN NV Competitive Strengths & Weaknesses
Table 115. Neogenomics Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Neogenomics Laboratories, Inc. Major Business
Table 117. Neogenomics Laboratories, Inc. Viable Tumor Samples Product and Services
Table 118. Neogenomics Laboratories, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Neogenomics Laboratories, Inc. Recent Developments/Updates
Table 120. Neogenomics Laboratories, Inc. Competitive Strengths & Weaknesses
Table 121. HTG Molecular Diagnostics Basic Information, Manufacturing Base and Competitors
Table 122. HTG Molecular Diagnostics Major Business
Table 123. HTG Molecular Diagnostics Viable Tumor Samples Product and Services
Table 124. HTG Molecular Diagnostics Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. HTG Molecular Diagnostics Recent Developments/Updates
Table 126. HTG Molecular Diagnostics Competitive Strengths & Weaknesses
Table 127. Genomic Health, Inc. Basic Information, Manufacturing Base and Competitors
Table 128. Genomic Health, Inc. Major Business
Table 129. Genomic Health, Inc. Viable Tumor Samples Product and Services
Table 130. Genomic Health, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Genomic Health, Inc. Recent Developments/Updates
Table 132. Genomic Health, Inc. Competitive Strengths & Weaknesses
Table 133. Thermo Fischer Basic Information, Manufacturing Base and Competitors
Table 134. Thermo Fischer Major Business
Table 135. Thermo Fischer Viable Tumor Samples Product and Services
Table 136. Thermo Fischer Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Thermo Fischer Recent Developments/Updates
Table 138. Thermo Fischer Competitive Strengths & Weaknesses
Table 139. BGI Genomics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 140. BGI Genomics Co., Ltd. Major Business
Table 141. BGI Genomics Co., Ltd. Viable Tumor Samples Product and Services
Table 142. BGI Genomics Co., Ltd. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. BGI Genomics Co., Ltd. Recent Developments/Updates
Table 144. BGI Genomics Co., Ltd. Competitive Strengths & Weaknesses
Table 145. Bruker Biosciences Corp. Basic Information, Manufacturing Base and Competitors
Table 146. Bruker Biosciences Corp. Major Business
Table 147. Bruker Biosciences Corp. Viable Tumor Samples Product and Services
Table 148. Bruker Biosciences Corp. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Bruker Biosciences Corp. Recent Developments/Updates
Table 150. Bruker Biosciences Corp. Competitive Strengths & Weaknesses
Table 151. Cepheid, Inc. Basic Information, Manufacturing Base and Competitors
Table 152. Cepheid, Inc. Major Business
Table 153. Cepheid, Inc. Viable Tumor Samples Product and Services
Table 154. Cepheid, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Cepheid, Inc. Recent Developments/Updates
Table 156. Cepheid, Inc. Competitive Strengths & Weaknesses
Table 157. Promega Corporation Basic Information, Manufacturing Base and Competitors
Table 158. Promega Corporation Major Business
Table 159. Promega Corporation Viable Tumor Samples Product and Services
Table 160. Promega Corporation Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Promega Corporation Recent Developments/Updates
Table 162. Promega Corporation Competitive Strengths & Weaknesses
Table 163. Applied Biosystems, Inc. Basic Information, Manufacturing Base and Competitors
Table 164. Applied Biosystems, Inc. Major Business
Table 165. Applied Biosystems, Inc. Viable Tumor Samples Product and Services
Table 166. Applied Biosystems, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Applied Biosystems, Inc. Recent Developments/Updates
Table 168. Applied Biosystems, Inc. Competitive Strengths & Weaknesses
Table 169. Natera Basic Information, Manufacturing Base and Competitors
Table 170. Natera Major Business
Table 171. Natera Viable Tumor Samples Product and Services
Table 172. Natera Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Natera Recent Developments/Updates
Table 174. Agilent Basic Information, Manufacturing Base and Competitors
Table 175. Agilent Major Business
Table 176. Agilent Viable Tumor Samples Product and Services
Table 177. Agilent Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Viable Tumor Samples Upstream (Raw Materials)
Table 179. Viable Tumor Samples Typical Customers
Table 180. Viable Tumor Samples Typical Distributors
Table 1. World Viable Tumor Samples Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Viable Tumor Samples Production Value by Region (2018-2023) & (USD Million)
Table 3. World Viable Tumor Samples Production Value by Region (2024-2029) & (USD Million)
Table 4. World Viable Tumor Samples Production Value Market Share by Region (2018-2023)
Table 5. World Viable Tumor Samples Production Value Market Share by Region (2024-2029)
Table 6. World Viable Tumor Samples Production by Region (2018-2023) & (K Units)
Table 7. World Viable Tumor Samples Production by Region (2024-2029) & (K Units)
Table 8. World Viable Tumor Samples Production Market Share by Region (2018-2023)
Table 9. World Viable Tumor Samples Production Market Share by Region (2024-2029)
Table 10. World Viable Tumor Samples Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Viable Tumor Samples Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Viable Tumor Samples Major Market Trends
Table 13. World Viable Tumor Samples Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Viable Tumor Samples Consumption by Region (2018-2023) & (K Units)
Table 15. World Viable Tumor Samples Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Viable Tumor Samples Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Viable Tumor Samples Producers in 2022
Table 18. World Viable Tumor Samples Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Viable Tumor Samples Producers in 2022
Table 20. World Viable Tumor Samples Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Viable Tumor Samples Company Evaluation Quadrant
Table 22. World Viable Tumor Samples Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Viable Tumor Samples Production Site of Key Manufacturer
Table 24. Viable Tumor Samples Market: Company Product Type Footprint
Table 25. Viable Tumor Samples Market: Company Product Application Footprint
Table 26. Viable Tumor Samples Competitive Factors
Table 27. Viable Tumor Samples New Entrant and Capacity Expansion Plans
Table 28. Viable Tumor Samples Mergers & Acquisitions Activity
Table 29. United States VS China Viable Tumor Samples Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Viable Tumor Samples Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Viable Tumor Samples Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Viable Tumor Samples Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Viable Tumor Samples Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Viable Tumor Samples Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Viable Tumor Samples Production Market Share (2018-2023)
Table 37. China Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Viable Tumor Samples Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Viable Tumor Samples Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Viable Tumor Samples Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Viable Tumor Samples Production Market Share (2018-2023)
Table 42. Rest of World Based Viable Tumor Samples Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Viable Tumor Samples Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Viable Tumor Samples Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Viable Tumor Samples Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Viable Tumor Samples Production Market Share (2018-2023)
Table 47. World Viable Tumor Samples Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Viable Tumor Samples Production by Type (2018-2023) & (K Units)
Table 49. World Viable Tumor Samples Production by Type (2024-2029) & (K Units)
Table 50. World Viable Tumor Samples Production Value by Type (2018-2023) & (USD Million)
Table 51. World Viable Tumor Samples Production Value by Type (2024-2029) & (USD Million)
Table 52. World Viable Tumor Samples Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Viable Tumor Samples Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Viable Tumor Samples Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Viable Tumor Samples Production by Application (2018-2023) & (K Units)
Table 56. World Viable Tumor Samples Production by Application (2024-2029) & (K Units)
Table 57. World Viable Tumor Samples Production Value by Application (2018-2023) & (USD Million)
Table 58. World Viable Tumor Samples Production Value by Application (2024-2029) & (USD Million)
Table 59. World Viable Tumor Samples Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Viable Tumor Samples Average Price by Application (2024-2029) & (US$/Unit)
Table 61. StoreMyTumor Basic Information, Manufacturing Base and Competitors
Table 62. StoreMyTumor Major Business
Table 63. StoreMyTumor Viable Tumor Samples Product and Services
Table 64. StoreMyTumor Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. StoreMyTumor Recent Developments/Updates
Table 66. StoreMyTumor Competitive Strengths & Weaknesses
Table 67. Cureline, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. Cureline, Inc. Major Business
Table 69. Cureline, Inc. Viable Tumor Samples Product and Services
Table 70. Cureline, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Cureline, Inc. Recent Developments/Updates
Table 72. Cureline, Inc. Competitive Strengths & Weaknesses
Table 73. Conversant Bio Basic Information, Manufacturing Base and Competitors
Table 74. Conversant Bio Major Business
Table 75. Conversant Bio Viable Tumor Samples Product and Services
Table 76. Conversant Bio Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Conversant Bio Recent Developments/Updates
Table 78. Conversant Bio Competitive Strengths & Weaknesses
Table 79. Fluxion Biosciences Basic Information, Manufacturing Base and Competitors
Table 80. Fluxion Biosciences Major Business
Table 81. Fluxion Biosciences Viable Tumor Samples Product and Services
Table 82. Fluxion Biosciences Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Fluxion Biosciences Recent Developments/Updates
Table 84. Fluxion Biosciences Competitive Strengths & Weaknesses
Table 85. Miltenyi Biotech Basic Information, Manufacturing Base and Competitors
Table 86. Miltenyi Biotech Major Business
Table 87. Miltenyi Biotech Viable Tumor Samples Product and Services
Table 88. Miltenyi Biotech Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Miltenyi Biotech Recent Developments/Updates
Table 90. Miltenyi Biotech Competitive Strengths & Weaknesses
Table 91. Crown Bioscience, Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Crown Bioscience, Inc. Major Business
Table 93. Crown Bioscience, Inc. Viable Tumor Samples Product and Services
Table 94. Crown Bioscience, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Crown Bioscience, Inc. Recent Developments/Updates
Table 96. Crown Bioscience, Inc. Competitive Strengths & Weaknesses
Table 97. Indivumed GmbH Basic Information, Manufacturing Base and Competitors
Table 98. Indivumed GmbH Major Business
Table 99. Indivumed GmbH Viable Tumor Samples Product and Services
Table 100. Indivumed GmbH Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Indivumed GmbH Recent Developments/Updates
Table 102. Indivumed GmbH Competitive Strengths & Weaknesses
Table 103. Illumina, Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Illumina, Inc. Major Business
Table 105. Illumina, Inc. Viable Tumor Samples Product and Services
Table 106. Illumina, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Illumina, Inc. Recent Developments/Updates
Table 108. Illumina, Inc. Competitive Strengths & Weaknesses
Table 109. QIAGEN NV Basic Information, Manufacturing Base and Competitors
Table 110. QIAGEN NV Major Business
Table 111. QIAGEN NV Viable Tumor Samples Product and Services
Table 112. QIAGEN NV Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. QIAGEN NV Recent Developments/Updates
Table 114. QIAGEN NV Competitive Strengths & Weaknesses
Table 115. Neogenomics Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Neogenomics Laboratories, Inc. Major Business
Table 117. Neogenomics Laboratories, Inc. Viable Tumor Samples Product and Services
Table 118. Neogenomics Laboratories, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Neogenomics Laboratories, Inc. Recent Developments/Updates
Table 120. Neogenomics Laboratories, Inc. Competitive Strengths & Weaknesses
Table 121. HTG Molecular Diagnostics Basic Information, Manufacturing Base and Competitors
Table 122. HTG Molecular Diagnostics Major Business
Table 123. HTG Molecular Diagnostics Viable Tumor Samples Product and Services
Table 124. HTG Molecular Diagnostics Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. HTG Molecular Diagnostics Recent Developments/Updates
Table 126. HTG Molecular Diagnostics Competitive Strengths & Weaknesses
Table 127. Genomic Health, Inc. Basic Information, Manufacturing Base and Competitors
Table 128. Genomic Health, Inc. Major Business
Table 129. Genomic Health, Inc. Viable Tumor Samples Product and Services
Table 130. Genomic Health, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Genomic Health, Inc. Recent Developments/Updates
Table 132. Genomic Health, Inc. Competitive Strengths & Weaknesses
Table 133. Thermo Fischer Basic Information, Manufacturing Base and Competitors
Table 134. Thermo Fischer Major Business
Table 135. Thermo Fischer Viable Tumor Samples Product and Services
Table 136. Thermo Fischer Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Thermo Fischer Recent Developments/Updates
Table 138. Thermo Fischer Competitive Strengths & Weaknesses
Table 139. BGI Genomics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 140. BGI Genomics Co., Ltd. Major Business
Table 141. BGI Genomics Co., Ltd. Viable Tumor Samples Product and Services
Table 142. BGI Genomics Co., Ltd. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. BGI Genomics Co., Ltd. Recent Developments/Updates
Table 144. BGI Genomics Co., Ltd. Competitive Strengths & Weaknesses
Table 145. Bruker Biosciences Corp. Basic Information, Manufacturing Base and Competitors
Table 146. Bruker Biosciences Corp. Major Business
Table 147. Bruker Biosciences Corp. Viable Tumor Samples Product and Services
Table 148. Bruker Biosciences Corp. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Bruker Biosciences Corp. Recent Developments/Updates
Table 150. Bruker Biosciences Corp. Competitive Strengths & Weaknesses
Table 151. Cepheid, Inc. Basic Information, Manufacturing Base and Competitors
Table 152. Cepheid, Inc. Major Business
Table 153. Cepheid, Inc. Viable Tumor Samples Product and Services
Table 154. Cepheid, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Cepheid, Inc. Recent Developments/Updates
Table 156. Cepheid, Inc. Competitive Strengths & Weaknesses
Table 157. Promega Corporation Basic Information, Manufacturing Base and Competitors
Table 158. Promega Corporation Major Business
Table 159. Promega Corporation Viable Tumor Samples Product and Services
Table 160. Promega Corporation Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Promega Corporation Recent Developments/Updates
Table 162. Promega Corporation Competitive Strengths & Weaknesses
Table 163. Applied Biosystems, Inc. Basic Information, Manufacturing Base and Competitors
Table 164. Applied Biosystems, Inc. Major Business
Table 165. Applied Biosystems, Inc. Viable Tumor Samples Product and Services
Table 166. Applied Biosystems, Inc. Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Applied Biosystems, Inc. Recent Developments/Updates
Table 168. Applied Biosystems, Inc. Competitive Strengths & Weaknesses
Table 169. Natera Basic Information, Manufacturing Base and Competitors
Table 170. Natera Major Business
Table 171. Natera Viable Tumor Samples Product and Services
Table 172. Natera Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Natera Recent Developments/Updates
Table 174. Agilent Basic Information, Manufacturing Base and Competitors
Table 175. Agilent Major Business
Table 176. Agilent Viable Tumor Samples Product and Services
Table 177. Agilent Viable Tumor Samples Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Viable Tumor Samples Upstream (Raw Materials)
Table 179. Viable Tumor Samples Typical Customers
Table 180. Viable Tumor Samples Typical Distributors
LIST OF FIGURES
Figure 1. Viable Tumor Samples Picture
Figure 2. World Viable Tumor Samples Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Viable Tumor Samples Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Viable Tumor Samples Production (2018-2029) & (K Units)
Figure 5. World Viable Tumor Samples Average Price (2018-2029) & (US$/Unit)
Figure 6. World Viable Tumor Samples Production Value Market Share by Region (2018-2029)
Figure 7. World Viable Tumor Samples Production Market Share by Region (2018-2029)
Figure 8. North America Viable Tumor Samples Production (2018-2029) & (K Units)
Figure 9. Europe Viable Tumor Samples Production (2018-2029) & (K Units)
Figure 10. China Viable Tumor Samples Production (2018-2029) & (K Units)
Figure 11. Japan Viable Tumor Samples Production (2018-2029) & (K Units)
Figure 12. Viable Tumor Samples Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 15. World Viable Tumor Samples Consumption Market Share by Region (2018-2029)
Figure 16. United States Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 17. China Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 18. Europe Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 19. Japan Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 20. South Korea Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 22. India Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Viable Tumor Samples by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Viable Tumor Samples Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Viable Tumor Samples Markets in 2022
Figure 26. United States VS China: Viable Tumor Samples Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Viable Tumor Samples Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Viable Tumor Samples Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Viable Tumor Samples Production Market Share 2022
Figure 30. China Based Manufacturers Viable Tumor Samples Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Viable Tumor Samples Production Market Share 2022
Figure 32. World Viable Tumor Samples Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Viable Tumor Samples Production Value Market Share by Type in 2022
Figure 34. Flash Frozen Tumor Samples
Figure 35. Fresh Tumor Samples
Figure 36. World Viable Tumor Samples Production Market Share by Type (2018-2029)
Figure 37. World Viable Tumor Samples Production Value Market Share by Type (2018-2029)
Figure 38. World Viable Tumor Samples Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Viable Tumor Samples Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Viable Tumor Samples Production Value Market Share by Application in 2022
Figure 41. Lung Cancer
Figure 42. Prostate Cancer
Figure 43. Breast Cancer
Figure 44. Lymphoma
Figure 45. Leukemia
Figure 46. Others
Figure 47. World Viable Tumor Samples Production Market Share by Application (2018-2029)
Figure 48. World Viable Tumor Samples Production Value Market Share by Application (2018-2029)
Figure 49. World Viable Tumor Samples Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Viable Tumor Samples Industry Chain
Figure 51. Viable Tumor Samples Procurement Model
Figure 52. Viable Tumor Samples Sales Model
Figure 53. Viable Tumor Samples Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Viable Tumor Samples Picture
Figure 2. World Viable Tumor Samples Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Viable Tumor Samples Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Viable Tumor Samples Production (2018-2029) & (K Units)
Figure 5. World Viable Tumor Samples Average Price (2018-2029) & (US$/Unit)
Figure 6. World Viable Tumor Samples Production Value Market Share by Region (2018-2029)
Figure 7. World Viable Tumor Samples Production Market Share by Region (2018-2029)
Figure 8. North America Viable Tumor Samples Production (2018-2029) & (K Units)
Figure 9. Europe Viable Tumor Samples Production (2018-2029) & (K Units)
Figure 10. China Viable Tumor Samples Production (2018-2029) & (K Units)
Figure 11. Japan Viable Tumor Samples Production (2018-2029) & (K Units)
Figure 12. Viable Tumor Samples Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 15. World Viable Tumor Samples Consumption Market Share by Region (2018-2029)
Figure 16. United States Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 17. China Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 18. Europe Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 19. Japan Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 20. South Korea Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 22. India Viable Tumor Samples Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Viable Tumor Samples by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Viable Tumor Samples Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Viable Tumor Samples Markets in 2022
Figure 26. United States VS China: Viable Tumor Samples Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Viable Tumor Samples Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Viable Tumor Samples Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Viable Tumor Samples Production Market Share 2022
Figure 30. China Based Manufacturers Viable Tumor Samples Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Viable Tumor Samples Production Market Share 2022
Figure 32. World Viable Tumor Samples Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Viable Tumor Samples Production Value Market Share by Type in 2022
Figure 34. Flash Frozen Tumor Samples
Figure 35. Fresh Tumor Samples
Figure 36. World Viable Tumor Samples Production Market Share by Type (2018-2029)
Figure 37. World Viable Tumor Samples Production Value Market Share by Type (2018-2029)
Figure 38. World Viable Tumor Samples Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Viable Tumor Samples Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Viable Tumor Samples Production Value Market Share by Application in 2022
Figure 41. Lung Cancer
Figure 42. Prostate Cancer
Figure 43. Breast Cancer
Figure 44. Lymphoma
Figure 45. Leukemia
Figure 46. Others
Figure 47. World Viable Tumor Samples Production Market Share by Application (2018-2029)
Figure 48. World Viable Tumor Samples Production Value Market Share by Application (2018-2029)
Figure 49. World Viable Tumor Samples Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Viable Tumor Samples Industry Chain
Figure 51. Viable Tumor Samples Procurement Model
Figure 52. Viable Tumor Samples Sales Model
Figure 53. Viable Tumor Samples Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
